TY  - RPRT
TI  - Selective inhibition of interleukin-2 inducible T cell kinase (ITK) enhances anti-tumor immunity in association with Th1-skewing, cytotoxic T cell activation, and reduced T cell exhaustion
AU  - Hsu, L.-Y.
AU  - Rosenbaum, J. T.
AU  - Verner, E.
AU  - Jones, W. B.
AU  - Hill, C. M.
AU  - Janc, J. W.
AU  - Buggy, J. J.
AU  - Ding, N.
AU  - Reneau, J. C.
AU  - Khodadoust, M. S.
AU  - Kim, Y. H.
AU  - Wilcox, R. A.
AU  - Miller, R. A.
PY  - 2023
DO  - 10.1101/2023.07.05.547822
UR  - https://www.biorxiv.org/content/10.1101/2023.07.05.547822v1
ID  - 10.1101/2023.07.05.547822
ER  -